 |
 |

Improvement in Heart Disease Risk Factors After Gastric Bypass
John J. Gleysteen, MD;
Joseph J. Barboriak, ScD
Arch Surg. 1983;118(6):681-684.
Abstract
 |  |
Fasting blood levels of three lipid classes (high-density lipoprotein—cholesterol [HDL-C], total cholesterol, and triglycerides) were measured in morbidly obese patients before, and six and 12 months after, Roux-en-Y gastric bypass. Weight above ideal in 31 women averaged 72 kg, and in 12 men, 78 kg. Excess weight lost after six months was 49.7%. Total cholesterol levels and abnormally high triglyceride levels (183±106 mg/dL [SD]) decreased and became normal after six months. Low-normal HDL-C levels in 31 women (45±13 mg/dL) improved by six months to 54±19 mg/dL; similarly, HDL-C levels in 12 men (38±9 mg/dL) increased to 57±17 mg/dL. One of eight diabetic patients remained hyperglycemic; ten of 15 patients who were hypertensive, requiring medication preoperatively, became normotensive by six months. Lipid levels measured again at one year showed little change. Risk factors of coronary heart disease were improved by gastric bypass in these morbidly obese patients, and the changes were clearly established by six months after operation.
(Arch Surg 1983;118:681-684)
Author Affiliations
From the Departments of Surgery (Dr Gleysteen) and Pharmacology (Dr Barboriak), Medical College of Wisconsin, Milwaukee, and Veteran's Administration Medical Center, Wood, Wis.
Footnotes
Accepted for publication Jan 17, 1983.
Read before the 90th annual meeting of the Western Surgical Association, Kansas City, Mo, Nov 17, 1982.
Reprint requests to Department of Surgery, Medical College of Wisconsin, 8700 W Wisconsin Ave, Milwaukee, WI 53226 (Dr Gleysteen).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Return to Work After Gastric Bypass in Medicaid-Funded Morbidly Obese Patients
Wagner et al.
Arch Surg 2007;142:935-940.
ABSTRACT
| FULL TEXT
Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome: A long-term follow-up study
Scopinaro et al.
Diabetes Care 2005;28:2406-2411.
ABSTRACT
| FULL TEXT
Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects
Faraj et al.
J. Clin. Endocrinol. Metab. 2003;88:1594-1602.
ABSTRACT
| FULL TEXT
Quality of Life: Cost and Future of Bariatric Surgery
Livingston and Fink
Arch Surg 2003;138:383-388.
FULL TEXT
The Effect of Gastric Bypass Surgery on Hypertension in Morbidly Obese Patients
Carson et al.
Arch Intern Med 1994;154:193-200.
ABSTRACT
Questions and Answers
JAMA 1989;261:1491-1494.
Reversal of Benign Intracranial Hypertension by Surgically Induced Weight Loss
Amaral et al.
Arch Surg 1987;122:946-949.
ABSTRACT
Morbid Obesity and Related Health Risks
KRAL
ANN INTERN MED 1985;103:1043-1047.
ABSTRACT
Gastric Restrictive Surgery for Morbid Obesity
Kral
JAMA 1985;254:2410-2411.
ABSTRACT
|